Related Experiment Videos
Proteolytic patterns of head and neck squamous cell carcinoma
M Schmidt1, C Polednik, F Hoppe
1Department of Otorhinolaryngology, University of Würzburg, Josef-Schneider-Strasse 11, D-97080 Würzburg, Germany.
Summary
This study quantifies protease activity in head and neck squamous cell carcinoma (SCC), finding increased matrix metalloproteinase-9 and urokinase plasminogen activator in tumors. However, these activities did not correlate with clinical outcomes or tumor characteristics.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- The role of plasminogen activators and matrix metalloproteases in head and neck squamous cell carcinoma (SCC) progression remains debated.
- Previous studies relied on limited quantitative methods like immunohistochemistry or in vitro experiments.
Purpose of the Study:
- To quantitatively analyze the expression of gelatinolytic and fibrinolytic proteases in head and neck SCC.
- To correlate protease activity and activation ratios with clinical and histopathological data.
Main Methods:
- Quantitative zymographic analysis was performed on 44 head and neck SCC and 11 adjacent mucosa samples.
- Activation ratios for matrix metalloproteinases-2 and -9 (MMP-2, MMP-9) were calculated by assessing inactive and active forms.
- Lytic activities were compared to clinical data, including T-stage, metastasis, necrosis, and differentiation.
Main Results:
- Head and neck SCC tissues exhibited significantly higher gelatinolytic and fibrinolytic activity compared to normal mucosa.
- Elevated activity was primarily attributed to matrix metalloproteinase-9 (MMP-9) and urokinase type plasminogen activator.
- No significant correlation was found between protease activity or activation ratios and tumor stage, metastasis, necrosis, or differentiation.
Conclusions:
- While MMP-9 and urokinase plasminogen activator are upregulated in head and neck SCC, their activity does not appear to predict clinical outcomes or tumor characteristics in this cohort.
- Further research is needed to elucidate the precise role of these proteases in head and neck cancer progression.